Page last updated: 2024-08-18
chalcone and Pulmonary Hypertension
chalcone has been researched along with Pulmonary Hypertension in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Han, X; Long, Y; Zhang, X; Zhang, Y; Zhou, Z | 1 |
Bai, Y; Cao, F; Dong, P; He, F; Hou, C; Li, L; Li, S; Song, Y; Sun, S; Zhu, D | 1 |
Other Studies
2 other study(ies) available for chalcone and Pulmonary Hypertension
Article | Year |
---|---|
Hydroxysafflor yellow A improves established monocrotaline-induced pulmonary arterial hypertension in rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Chalcone; Deoxyguanosine; Gene Expression Regulation; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Inflammation; Male; Malondialdehyde; Monocrotaline; Oxidative Stress; Quinones; Rats, Wistar; RNA, Messenger; Superoxide Dismutase; Vascular Remodeling | 2016 |
Hydroxysafflor yellow A (HSYA) attenuates hypoxic pulmonary arterial remodelling and reverses right ventricular hypertrophy in rats.
Topics: Animals; Carthamus tinctorius; Cell Survival; Cells, Cultured; Chalcone; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; Myocytes, Smooth Muscle; Phytotherapy; Pulmonary Artery; Quinones; Rats, Wistar; Vascular Remodeling | 2016 |